Haoxi Health Technology Ltd (HAO) Form 6-K — Jul 13, 2026
Haoxi Health Technology Limited closed a registered direct offering for gross proceeds of $4,000,000, assuming the full exercise of 9,700,000 pre-funded warrants. The company sold 300,000 Class A ordinary shares at a price of $0.40 per share and 9,700,000 pre-funded warrants at $0.07 per warrant, which are exercisable at $0.33 per share. Univest Securities, LLC acted as the placement agent, receiving a cash fee equal to 7% of the gross proceeds plus reimbursement of up to $60,000 in expenses. The net proceeds are intended for working capital, operating expenses, capital expenditures, potential acquisitions, and other general corporate purposes.
Key figures
- Gross Proceeds
- 4000000
- Share Price
- 0.4
- Shares Issued
- 300000
- Warrant Price
- 0.07
- Warrants Issued
- 9700000
- Lockup Period Days
- 90
- Warrant Exercise Price
- 0.33
- Placement Agent Fee Percent
- 7
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.